市场调查报告书
商品编码
1245681
全球分析仪器市场规模、份额、行业趋势分析报告:按产品(仪器、软件、服务)、技术、应用、地区、展望和预测,2022-2028 年Global Analytical Instrumentation Market Size, Share & Industry Trends Analysis Report By Product (Instruments, Software and Services), By Technology, By Application, By Regional Outlook and Forecast, 2022 - 2028 |
到 2028 年,全球分析仪器市场规模预计将达到 664 亿美元,预测期内復合年增长率为 4.0%。
公司也在开发创新技术并开发未开发的市场潜力,以满足不断增长的需求,这是由分析仪器的技术进步推动的。此外,随着精准医学的进步,分析仪器解决方案的使用有望增加。为了识别疾病和创建定制治疗,精准医学利用分析仪器进行下一代测序、分子成像、分子动力学和分子诊断。
例如,在分子诊断学中,进行基因组测序以分析患者的生物标誌物。使用各种分析工具执行此类测试还可以提供有关最佳治疗过程的知识,甚至可以为特定患者预测最合适的治疗方法。此外,在药物开发过程中,显微镜和冷冻电子显微镜等技术被广泛用于研究蛋白质等生物体的三维结构。
COVID-19 影响分析
由于COVID-19大流行,热分析仪、光谱仪和色谱相关仪器等分析仪器业务已经收缩。这是由于严格法规的实施、供应链的中断以及同时临床试验的减少。但受疫情影响,2021年PCR、芯片、测序仪技术相关设备需求大幅增加。在此期间,已经推出了几种新的 PCR 产品,以满足越来越多的 COVID-19 病例。伴随着产品需求的不平衡,出现了产品交付延迟等问题,阻碍了分析仪器行业的供应链。
市场增长因素
高精尖医学发展突飞猛进
为此,正在推动精准诊疗方法的发展,以及下一代测序(NGS)和大规模基因组数据的发展。此外,在基因治疗和开髮用于治疗癌症、肺结核和阿尔茨海默病等疾病的精准药物方面也取得了重大进展。因此,越来越多的製药和生物技术公司开始进入这个市场。因此,分析仪器市场的增长受到精准医疗的推动,精准医疗提供个性化的药物和治疗。
在水和废水处理中越来越多地使用分析仪器
水和废水中存在色谱法等许多过程。因此,色谱领域的发展离不开大数据、人工智能等前沿技术的融合。鑑于色谱分析过程中产生的大量数据,此类技术有望实现数据分类自动化并提高定量结果的可信度。因此,各种研发活动对分析仪器的需求,主要用于评估水和废水处理的特性和参数,正在推动市场增长。
市场製约因素
缺乏熟练的专业人员来操作分析仪器
随着技术的进步,分析仪器变得越来越复杂,需要熟练的工作人员有效地处理它们。另一个主要障碍是缺乏建立测试设施的基础设施。由于製造业分散且通常规模较小,因此在许多发展中国家很难从这些公司中抽样。缺乏机构合作和设备不足是另外两个关键问题。因此,合格专业人员的短缺将限制最终用户对测试设备和耗材的采用,从而减缓市场增长。
产品前景
基于产品,分析仪器市场分为仪器、服务和软件。2021年的分析仪器市场,软件板块获得了可观的增速。在学术研究和临床诊断等各种环境下的分析工作中,软件经常用于数据处理和结果解释。例如,借助流式细胞仪软件进行数据采集和控制,然后对结果进行统计分析。预计此类软件功能将在预测期内推动该细分市场的扩张。
技术展望
按技术划分,分析仪器市场分为聚合□链反应、光谱学、显微镜、色谱、流式细胞术、测序仪、微阵列等。2021 年,色谱部门在分析仪器市场中占据了重要的收入份额。生命科学、製药等领域的多样化应用是该细分市场崛起的主要原因。色谱的三种类型是气相色谱、液相色谱和离子色谱。复杂的蛋白质组学研究是使用液相色谱法发现的。离子色谱用于需要质量控制的领域,例如环境检测。
应用前景
根据应用,分析仪器市场分为生命科学研发、临床和诊断分析、食品和饮料分析、法医分析、环境测试等。2021 年,临床和诊断分析部门在分析仪器市场中占据了相当大的收入份额。癌症和慢性病患病率的上升预计将推动对诊断测试的强劲需求,推动对分析仪器产品(如用于临床测试的流式细胞仪)的需求。此外,临床实验室新分析仪器的批准和引进预计将推动该领域的增长。这使得快速、廉价和准确地识别样品成为可能。
区域展望
按地区划分,对北美、欧洲、亚太地区和 LAMEA 的分析仪器市场进行了分析。2021 年,北美市场在分析仪器市场的收入份额最高。这一巨大的市场份额归功于该地区完善的製药行业和医疗保健系统,对临床和研究应用的分析仪器产生了巨大的需求。此外,大量旨在开发针对各种疾病的疫苗和药物的研发项目,以及公共和私营部门对癌症研究的广泛支持,也刺激了对分析和测量仪器的需求。我在玩
市场进入者采取的主要策略是“收购”。根据发表在 Cardinal Matrix 上的分析,F. Hoffmann-La Roche Ltd.、Thermo Fisher Scientific Inc. 和 Danaher Corporation 在分析仪器市场处于领先地位。Bio-Rad Laboratories, Inc.、Carl Zeiss AG 和 Agilent Technologies, Inc. 等公司是分析仪器市场的领先创新者。
The Global Analytical Instrumentation Market size is expected to reach $66.4 billion by 2028, rising at a market growth of 4.0% CAGR during the forecast period.
Analytical instrumentation is laboratory equipment used to investigate the separation, identification, and quantification of chemical components in both natural and synthetic materials. These analytical tools are employed to gather quantitative and qualitative data regarding the existence of a number of components in a particular sample. These tools are also used in a wide range of clinical diagnostic procedures as well as life sciences research to create new therapeutic and diagnostic products.
Pharmaceutical and biotechnology sectors have emerged as the leading end-users of analytical equipment due to their significant usage of these tools throughout the drug development process as a result of their vast R&D activities. Pharmaceutical enterprises are actively engaging and investing in R&D for the development of advanced and efficient products. Consequently, increased R&D investments and instrument adoption rates are likely to drive market growth.
In addition, enterprises are developing innovative technologies to fulfil expanding demand and exploit untapped market potential, which is being driven by the technological advancement of analytical instrumentation. Additionally, the use of analytical instrumentation solutions is anticipated to increase due to the growing development of precision medicine. In order to identify illnesses and create customized therapies, precision medicine utilizes analytical instrumentation for next-generation sequencing, molecular imaging, molecular dynamics, and molecular diagnostics.
For example, genomic sequencing is used in molecular diagnostics to analyze a patient's biomarkers. These tests carried out with different analytical tools, provide knowledge on the optimal course of action or even forecast the treatments that are most appropriate for a specific patient. Additionally, the 3D structures of biological organisms like proteins are widely studied using microscopes and techniques like cryogenic electron microscopy in the drug development process.
COVID-19 Impact Analysis
The COVID-19 pandemic caused a decline in the business of analytical instruments, including heat analyzers, spectroscopy, and chromatography-related equipment. This was brought on by the implementation of severe lockdown regulations, the interruption of supply networks, and a decline in clinical trial activity during that time. However, the pandemic caused a huge increase in demand for PCR, microarray, and sequencing technology-related instruments in 2021. Several novel PCR products were introduced during this time to address the rising COVID-19 cases. Problems like late product delivery along with an uneven demand for goods, hampered the supply chain of the analytical instruments industry.
Market Growth Factors
Rapid advancement in the development of precision medicine
This has propelled significant improvements in precision diagnoses and therapeutics as well as developments like next generation sequencing (NGS) and large genomic data. Additionally, there have been significant developments in gene therapy and the creation of precision medicines to treat ailments like cancer, TB, and Alzheimer's. As a result, more pharmaceutical and biotech businesses are starting to enter this market. Therefore, the growth of the analytical instrumentation market is being booted by the rise of precision medicine, providing individualized medicines and treatments.
Increasing usage of analytical instrumentation in water and wastewater treatment
Water and wastewater involve many processes, like chromatography. Therefore, the chromatography sector's development is driven by the incorporation of cutting-edge technologies like Big Data and artificial intelligence (AI). Such technologies are anticipated to automate the categorization of data and enhance the reliability of quantitative results due to the large amount of data generated during chromatography. Therefore, the requirement of analytical instrumentation in different R&D activities mainly to evaluate the characteristics and parameters of water & wastewater treatment is accelerating the market growth.
Market Restraining Factors
Dearth of skilled professionals to operate analytical equipment
The complexity of analytical instruments has significantly risen due to technological improvements, making it necessary to have a skilled crew handle them efficiently. Another significant obstacle is the lack of supporting infrastructure to establish testing facilities. Due to the fragmentation and predominance of small businesses in the manufacturing industry, sample collection from these businesses might be difficult for testing service providers in many developing nations. Lack of institutional cooperation and equipment shortage are two other significant problems. As a result, the lack of qualified specialists will probably limit how widely laboratory instruments and consumables are used by end users, thus slowing the market's growth.
Product Outlook
Based on product, the analytical instrumentation market is categorized into instruments, services, and software. The software segment procured a considerable growth rate in the analytical instrumentation market in 2021. Software is frequently utilized in various contexts, including academic research and clinical diagnosis, for data processing and result interpretation in analytical operations. For instance, with the help of flow cytometry software data is acquired & controlled, after which the results are statistical analysis is done. Over the course of the projected period, such software abilities are expected to fuel segment expansion.
Technology Outlook
On the basis of technology, the analytical instrumentation market is divided into polymerase chain reaction, spectroscopy, microscopy, chromatography, flow cytometry, sequencing, microarray, and others. The chromatography segment recorded a significant revenue share in the analytical instrumentation market in 2021. The diverse applications in life science, pharmaceutical, and other areas are mostly accountable for the segment's rise. The three types of chromatography are gas, liquid, and ion. Complex proteomic studies are discovered using liquid chromatography. Ion chromatography techniques are employed in fields where quality control is necessary like environmental testing.
Application Outlook
Based on application, the analytical instrumentation market is segmented into life sciences research & development, clinical & diagnostic analysis, food & beverage analysis, forensic analysis, environmental testing, and others. The clinical & diagnostic analysis segment acquired a substantial revenue share in the analytical instrumentation market in 2021. There is a strong demand for diagnostic tests due to the rising prevalence of cancer and chronic diseases, which is projected to fuel demand for analytical equipment goods like flow cytometers for clinical testing. Additionally, it is projected that the approval and introduction of novel analytical apparatus for clinical laboratories will accelerate segment growth. This makes it possible to identify samples quickly, cheaply, and accurately.
Regional Outlook
On the basis of region, the analytical instrumentation market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America segment witnessed the highest revenue share in the analytical instrumentation market in 2021. This considerable market share can be due to the region's established pharmaceutical sector and healthcare system, which have generated a sizable demand for analytical instruments for clinical and research applications. The need for analytical instruments and instrumentation have also been spurred by high number of R&D projects that aim to develop vaccines and medicines for different diseases and by engaging more public-private support in cancer research.
The major strategies followed by the market participants are Acquisition. Based on the Analysis presented in the Cardinal matrix; F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc. and Danaher Corporation are the forerunners in the Analytical Instrumentation Market. Companies such as Bio-Rad Laboratories, Inc., Carl Zeiss AG, and Agilent Technologies, Inc. are some of the key innovators in Analytical Instrumentation Market.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., PerkinElmer, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Carl Zeiss AG, Danaher Corporation, Bruker Corporation, F. Hoffmann-La Roche Ltd., and Mettler-Toledo International, Inc.
Recent Strategies Deployed in Analytical Instrumentation Market
Mergers & Acquisition
Jan-2023: Thermo Fisher Scientific Inc. took over The Binding Site Group, a global leader in specialty diagnostics. Through this acquisition, Thermo Fisher Scientific Inc. would be able to extend its current specialty diagnostics portfolio along with pioneering innovation in monitoring and diagnostics for numerous myelomas.
Jan-2023: Carl Zeiss AG took over LENSO Sp. Z.o.o, a company that works in the field of servicing manufacturing companies in the field of precise industrial metrology. Through this acquisition, Carl Zeiss AG would be able to provide a fluent and combined experience to get the finest measuring solutions for the specific applications for its customers.
Mar-2022: Thermo Fisher Scientific, Inc., acquired Max Analytical Technologies, a producer of FTIR-based gas analysis solutions for process monitoring, source testing, and ambient air monitoring. Through this acquisition, Thermo Fisher Scientific, Inc., would be able to complete and extend its Software, FTIR instrument, and service offerings. Moreover, this acquisition would aid Thermo Fisher Scientific, Inc., to grow the range of vibrational spectroscopy services and solutions across a spectrum of market segments.
Feb-2022: Agilent Technologies Inc., took over Virtual Control's Advanced Artificial Intelligence (AI) Technology. Through this acquisition, Agilent Technologies Inc. would be able to combine the software into its industry-leading gas mass spectrometry and chromatography (GS/MS) platforms to enhance the efficiency, accuracy, and productivity of high-throughput labs.
Jun-2020: Illumina, Inc. took over BlueBee, a cloud-based software company that provides genomics analysis solutions for research and clinical customers. Through this acquisition, Illumina, Inc. would be able to combine BlueBee's abilities into its cloud portfolio which would further provide users the flexibility to operate their custom analyses or access industry-leading options. Moreover, this would lead to the most efficient, extensible, and scalable genomic analysis solutions for both translational and clinical research use cases.
Apr-2020: Bio-Rad Laboratories, Inc. took over Celsee, Inc., a company that offers instruments and consumables for the isolation, detection, and analysis of single cells. Through this acquisition, Bio-Rad Laboratories, Inc. would expand its spread into the fast-growing world of single-cell analysis and precision medicine, both of which contribute to an improved understanding of diagnosis, treatment, and disease with the help of Celsee's technologies and products.
Aug-2019: Agilent Technologies, Inc., took over BioTek Instruments, a global leader in the design, manufacture, and distribution of innovative life science instrumentation. Through this acquisition, Agilent Technologies, Inc. would be able to extend its growing existence and expertise in cell analysis. Moreover, this would strengthen the company's standing in the growing and immense immunotherapy and immuno-oncology areas.
May-2018: PerkinElmer, Inc. took over Shanghai Spectrum Instruments Co., Ltd, one of the leading manufacturers of analytical instruments in China. Through this acquisition, PerkinElmer, Inc. intends to construct SSI's manufacturing capabilities and R&D in China to supply continuous software and hardware creations for its customers and support China's purpose of strengthening local manufacturing.
Mar-2018: Agilent Technologies Inc., acquired Advanced Analytical Technologies, Inc., a provider of capillary electrophoresis-based (CE) solutions for the fully-automated analysis of a range of molecules. Through this acquisition, Agilent Technologies Inc. would be able to improve its current technology and expertise while providing customers with a better complete group of solutions.
Product Launch and Product Expansions
Sep-2022: Perkinelmer, Inc. launched Dubbed Cellaca PLX Image Cytometry System. The new platform enables researchers to assess various critical quality attributes of cell samples, including quality, quantity, and identity of cells, in one automated workflow.
Sep-2022: PerkinElmer, Inc. unveiled Cellaca PLX Image Cytometry System. This new product allows researchers to evaluate multiple Critical Quality Attributes (CQAs) of cell samples in a single automated workflow, including Quality, Quantity, and Cell Identity. Additionally, the Cellaca PLX integrates superior image cytometer software, hardware, trackable data, and validated consumables reporting all in one system without needing intense training requirements or complex calibration procedures.
Jun-2022: Agilent Technologies, Inc., launched new LC/MS and GC/MS quadrupole mass spectrometers. The new GC/TQ and LC/TQ products propose built-in instrument intelligence to streamline lab operations. Additionally, the new GC/TQ and GC/SQ products with the HydroInert source aid customers overcome key performance challenges with hydrogen carrier gas.
Feb-2022: Thermo Fisher Scientific Inc., launched a new portfolio of Chromatography and Mass Spectrometry consumables. This new product is crafted to fulfill higher performance needs while staying economical. Additionally, a new collection of vials, kits, caps, inserts, mats, and well plates would further enhance sample security and analytical performance for mass spectrometry and chromatography users in research and routine laboratories.
Mar-2020: Thermo Fisher Scientific Inc., unveiled the new Thermo Scientific Vanquish Core HPLC Systems. This new product would be able to extend the performance of the Vanquish platform to deliver a productivity-enhancing solution for routine laboratories.
Partnerships, Collaborations & Agreements
Jun-2021: Bio-Rad Laboratories, Inc. partnered with Seegene, Inc., a global leader in multiplex molecular diagnostics. Through this partnership, Bio-Rad Laboratories, Inc. would be able to use the diagnostic tests offered by Seegene, Inc. for its CFX96™ Dx Real-Time PCR System for clearance from The U.S. Food & Drug Administration (FDA) and U.S. markets pending clinical development.
Sep-2019: Thermo Fisher Scientific, Inc., came into collaboration with Cedars-Sinai, a leading nonprofit academic healthcare organization. Under this collaboration, Thermo Fisher Scientific, Inc., would target to deliver clinical research laboratories with sensitive and specific LC-MS-based workflows that would further provide improved confidence in data while witnessing and examining novel or comprehended protein-based biomarkers within biological matrices.
Market Segments covered in the Report:
By Product
By Technology
by Application
By Geography
Companies Profiled
Unique Offerings from KBV Research
List of Figures